Insights into Anti-metastais therapy for Melanoma: ATRA (a derivative of Vitamin-A) suppresses the expression of MLK3 (Mixed lineage kinase-3) via up regulation of its target gene, 19/March/2014, 22.47

Insights into Anti-metastais therapy for Melanoma: ATRA (a derivative of Vitamin-A) suppresses the expression of MLK3 (Mixed lineage kinase-3) via up regulation of its target gene, 19/March/2014, 22.47

Insights into Anti-metastais therapy for Melanoma: ATRA (a derivative of Vitamin-A) suppresses the expression of MLK3 (Mixed lineage kinase-3) via up regulation of its target gene, 19/March/2014, 22.47 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Insights into Anti-metastais therapy for Melanoma:  ATRA (a derivative of Vitamin-A) suppresses the expression of MLK3 (Mixed lineage kinase-3) via up regulation of its target gene, 19/March/2014, 22.47,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing